Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Kidney Transplant: early-phase trial registry
16 of 31 indexed Kidney Transplant trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #495 of 28,707 conditions by registered trial count.
31 US clinical trials · 16 currently recruiting · #495 of 28,707 conditions by registered trial count
Kidney Transplant: 31 US clinical trials tracked, 16 recruiting.
Kidney Transplant is the subject of 31 registered US clinical trials on ClinicalTrials.gov, 16 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 6 of these trials.
Enrollment posture brief
Registry condition kidney-transplant
OPEN 16 | RECR 52% | LATE 7 | EARLY 12 | RANK #495 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Cutaneous Melanoma (52% recruiting · 31 trials)
Kidney Transplant lists 16 open slots (52% of 31 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Kidney Transplant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Kidney Transplant is recruiting above its size-band peers.
16 of 31 indexed trials (51.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Kidney Transplant research.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 6 of 31 trials (19.4%). 24 distinct sponsors appear on at least one study for this condition label.
-
Most Kidney Transplant trials plan to enrol fewer than 100 people.
Median target enrolment is 62 among the 31 trials that report a genuine target (sentinel values excluded). 19 of those (61.3%) plan for fewer than 100 participants.
-
Kidney Transplant splits between interventional and observational designs.
21 interventional and 10 observational studies make up this index (67.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
31 total, page 1 of 1
The KidneyCARE (Community Access to Research Equity) Study
Tufts Medical Center
NCT05497518
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)
NCT05917522
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
Alexion Pharmaceuticals
NCT06830798
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
Devyser
NCT07006831
Empagliflozin Treatment in Kidney Transplant Recipients
VA Office of Research and Development
NCT06013865
Advancing Transplantation Outcomes in Children
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06055608
Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06919003
Social Support Counseling Intervention for Kidney Transplant Candidates
Hennepin Healthcare Research Institute
NCT06147076
The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease
Brigham and Women's Hospital
NCT07222683
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
Mayo Clinic
NCT06752577
Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)
University of Kansas Medical Center
NCT06640179
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Travere Therapeutics
NCT07219121
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06056102
Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Jeffrey Veale, MD
NCT03707262
Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients
Mayo Clinic
NCT05456243
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Vertex Pharmaceuticals Incorporated
NCT06832410
Pro-active Genetic Testing in Kidney Transplant Patients
Mayo Clinic
NCT05298904
Microbiome and Immunosuppression: The Mission Study
The University of Texas Medical Branch, Galveston
NCT04953715
TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation
University of California, Los Angeles
NCT07287800
Immunogenicity of HPV Vaccine in Transplant Recipients.
Medical College of Wisconsin
NCT05557370
Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study
Angus W. Thomson PhD DSc
NCT03726307
A Study of Factors That Affect Long-Term Kidney Transplant Function
University of Minnesota
NCT00270712
Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01289717
Natural History Study of Azathioprine Adherence
Thomas E. Nivens, MD
NCT00143910
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
University of Florida
NCT03527238
Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients
Martina McGrath, MD
NCT05405556
Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients
Temple University
NCT03713645
Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 Diabetes
The Cleveland Clinic
NCT07271433
COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study
National Institute of Allergy and Infectious Diseases (NIAID)
NCT05518487
A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients
Roberto Gedaly
NCT03284242
Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer
The Rogosin Institute
NCT03229265
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 6 |
| Phase 3 | 2 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Kidney Transplant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Kidney Transplant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Kidney Transplant page
31 registered trials, 16 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 16 Kidney Transplant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most Kidney Transplant trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Transplant condition card totals 31 registered trials; most-linked intervention Treg; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.